Skip NavigationSkip to Content

IL28B Polymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection

  1. Author:
    Martin, M. P.
    Qi, Y.
    Goedert, J. J.
    Hussain, S. K.
    Kirk, G. D.
    Hoots, W. K.
    Buchbinder, S.
    Carrington, M.
    Thio, C. L.
  2. Author Address

    [Kirk, Gregory D.; Thio, Chloe L.] Johns Hopkins Univ, Baltimore, MD 21205 USA. [Martin, Maureen P.; Qi, Ying; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick, Frederick, MD 21701 USA. [Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA. [Hoots, W. Keith] NHLBI, Div Blood Dis & Resources, Bethesda, MD 20892 USA. [Hussain, Shehnaz K.] Univ Calif Los Angeles, Los Angeles, CA USA. [Buchbinder, Susan] Univ Calif San Francisco, San Francisco, CA 94143 USA.;Thio, CL, Johns Hopkins Univ, 855 N Wolfe St,Ste 520, Baltimore, MD 21205 USA.;cthio@jhmi.edu
    1. Year: 2010
    2. Date: Dec
  1. Journal: Journal of Infectious Diseases
    1. 202
    2. 11
    3. Pages: 1749-1753
  2. Type of Article: Article
  3. ISSN: 0022-1899
  1. Abstract:

    An IL28B haplotype strongly determines the outcome of natural and interferon-alpha treated hepatitis C virus (HCV) infection. To assess whether the polymorphism marking the haplotype (rs12979860) also affects other interferon-alpha responsive chronic viral illnesses, namely hepatitis B virus (HBV) and human immunodeficiency virus (HIV) type 1 infections, we genotyped 226 individuals with HBV persistence, 384 with HBV recovery, and 2548 with or at high risk for HIV infection. The C/C genotype of rs12979860 was not associated with HBV recovery (odds ratio, 0.99), resistance to HIV infection (odds ratio, 0.97), or HIV disease progression (P>1.05). This IL28B single-nucleotide polymorphism affects the immune response to HCV but not to HBV or HIV.

    See More

External Sources

  1. DOI: 10.1086/657146
  2. WOS: 000283799900019

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel